Tag: Vutrisiran

Remote patient monitoring did not reduce heart failure readmissions: The BEAT-HF trial

Vutrisiran reduces mortality in transthyretin amyloidosis with cardiomyopathy

byKiera Liblikand1 others

March 5, 2025

1. Vutrisiran treatment reduced the risk of death and recurrent cardiovascular events compared to placebo in patients with transthyretin amyloidosis ...

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

Renal point-of-care ultrasound may be effective at identifying patients with nephrolithiasis
Shorter antibiotic courses non-inferior for inpatient community-acquired pneumonia
2 Minute Medicine Rewind April 13, 2026

No Result

View All Result